Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|November 7, 1998
Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and ThaisJ A Lynch, M deSouza, M D Robb, et al.
Developments in Biological Standardization|January 1, 1978
Comparative study on antibody determination by different methods in sera of persons vaccinated with HDCS rabies vaccineE K Kuwert, O Thraenhart, I Marcus, et al.
Zentralblatt Fur Bakteriologie, Parasitenkunde, Infektionskrankheiten Und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie Und Parasitologie|October 1, 1978
Comparative study on antibody determination by different methods in sera of persons vaccinated with HDCS-vaccineE K Kuwert, O Thraenhart, I Marcus, et al.
AIDS Research and Human Retroviruses|August 10, 2000
A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North AmericansM S de Souza, C Karnasuta, A E Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 1998
Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4J H Horspool, P J Perrin, J B Woodcock, et al.
Developments in Biological Standardization|January 1, 1978
Comparison studies on potency tests for rabies vaccinesT J Wiktor, P Atanasiu, M Bahmanyar, et al.
AIDS Research and Human Retroviruses|May 18, 2007
Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responsesA Rutebemberwa, J W Bess, B Brown, et al.
The Journal of Infectious Diseases|October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infectionL D Loomis-Price, J H Cox, J R Mascola, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.
Pageof 9